Recruiting
Phase 3

Triptorelin

Sponsor:

Children's Oncology Group

Code:

NCT06513962

Conditions

Hematopoietic and Lymphatic System Neoplasm

Malignant Solid Neoplasm

Eligibility Criteria

Sex: Female

Age: 0 - 39

Healthy Volunteers: Not accepted

Interventions

Best Practice

Biospecimen Collection

Electronic Health Record Review

Survey Administration

Triptorelin Pamoate

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-25. This information was provided to ClinicalTrials.gov by Children's Oncology Group on 2025-03-19.